Organon (OGN) Change in Cash (2021 - 2026)
Organon (OGN) recorded quarterly Change in Cash of $542.0 million in Q1 2026, up 653.06% quarter-over-quarter from -$98.0 million in Q4 2025, and up 523.44% on a YoY basis from $86.9 million in Q1 2025.
Organon (OGN) Change in Cash (2021 - 2026) Analysis & Trends
Organon's Change in Cash history runs 6 years deep, the most recent figure standing at $542.0 million for Q1 2026.
- In Q1 2026, Change in Cash rose 523.44% year-over-year to $542.0 million; the TTM figure through Mar 2026 stood at $569.0 million (up 2132.14% YoY), while the FY2025 annual figure was -$101.0 million, down 461.11% from the prior year.
- Change in Cash was $542.0 million for Q1 2026 at Organon, up from -$98.0 million in the prior quarter.
- In the past five years, Change in Cash ranged from a high of $542.0 million in Q1 2026 to a low of -$247.0 million in Q1 2023.
- Historically, Change in Cash has averaged $22.3 million across 5 years, with a median of -$43.0 million in 2022.
- The sharpest annual moves came in 2023 and 2026: Change in Cash tumbled 474.42% in 2023, then soared 523.44% in 2026.
- A 5-year view of Change in Cash shows it stood at $207.0 million in 2022, then soared by 34.78% to $279.0 million in 2023, then tumbled by 131.54% to -$88.0 million in 2024, then dropped by 11.36% to -$98.0 million in 2025, then soared by 653.06% to $542.0 million in 2026.
- The last three Change in Cash figures came in at $542.0 million (Q1 2026), -$98.0 million (Q4 2025), and $73.0 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Gsk | 93,026,132.38 Bn | 93,026,127.42 Bn | 7.76 Bn | -71.45 Mn |
| 2 | Eli Lilly | 1,022.62 Bn | 1,017.34 Bn | 16.22 Bn | -1.99 Bn |
| 3 | Johnson & Johnson | 570.65 Bn | 548.59 Bn | 15.96 Bn | 1.98 Bn |
| 4 | AbbVie | 398.73 Bn | 389.38 Bn | 10.78 Bn | 4.16 Bn |
| 5 | Merck | 295.53 Bn | 289.88 Bn | 12.09 Bn | -9.29 Bn |
| 6 | Amgen | 186.30 Bn | 174.26 Bn | 5.87 Bn | 2.91 Bn |
| 7 | Gilead Sciences | 155.93 Bn | 148.21 Bn | 5.52 Bn | 65.00 Mn |
| 8 | Pfizer | 146.09 Bn | 133.32 Bn | -1.21 Bn | 563.00 Mn |
| 9 | Bristol Myers Squibb | 114.98 Bn | 104.53 Bn | 8.07 Bn | -635.00 Mn |
| 10 | Organon | 3.49 Bn | 2.37 Bn | 783.00 Mn | 542.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 542.00 Mn |
| Dec 31, 2025 | -98.00 Mn |
| Sep 30, 2025 | 73.00 Mn |
| Jun 30, 2025 | 52.00 Mn |
| Mar 31, 2025 | -128.00 Mn |
| Dec 31, 2024 | -88.00 Mn |
| Sep 30, 2024 | 59.00 Mn |
| Jun 30, 2024 | 129.00 Mn |
| Mar 31, 2024 | -118.00 Mn |
| Dec 31, 2023 | 279.00 Mn |
| Sep 30, 2023 | 88.00 Mn |
| Jun 30, 2023 | -133.00 Mn |
| Mar 31, 2023 | -247.00 Mn |
| Dec 31, 2022 | 207.00 Mn |
| Sep 30, 2022 | -46.00 Mn |
| Jun 30, 2022 | -149.00 Mn |
| Mar 31, 2022 | -43.00 Mn |
| Dec 31, 2021 | -271.00 Mn |
| Sep 30, 2021 | 278.00 Mn |
| Jun 30, 2021 | 569.00 Mn |